Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Bayer AG
  6. News
  7. Summary
    BAYN   DE000BAY0017

BAYER AG

(BAYN)
  Report
Real-time Estimate Tradegate  -  12:45 2022-09-30 pm EDT
47.42 EUR   -0.63%
09/28Bayer CropScience Gets Board Nod to Sell Environmental Science Business for Nearly $14 Million
MT
09/27Sandoz Granted Leave To Add New Allegations On Condition Of Trial Adjournment And Extension Of 24-month Stay
AQ
09/27Santen Pharmaceutical Co., Ltd. - Ophthalmic VEGF inhibitor Eylea Solution for Intravitreal Injection 40 mg/mL obtains approval for ROP as sixth indication
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Bayer : Access to Seeds Index ranks Bayer 2nd on efforts to support smallholder farmers in Asia

11/12/2018 | 05:48am EDT

Monheim, November 12, 2018 - During the 25th Asian Seed Congress, the Access to Seeds Foundation will present its first Regional Index for South & Southeast Asia in Manila, the Philippines. Out of the 24 seed companies evaluated for their activities in 2016/17, Bayer was ranked No. 2, showing 'consistently high scores across all measurement areas,' the Index reports.

'We are proud that our efforts to grant smallholder farmers access to high-quality seeds and help them grow their businesses are recognized,' said Jens Hartmann, Head of the Asia Pacific Region for the Crop Science Division of Bayer. 'Companies like Bayer play an important role in improving access to seeds for farmers in emerging markets like South and Southeast Asia. The ranking shows we are on the right track, and motivates us to do even better in the future. We already leverage our deep experience in rice, millet and cotton. With the integration of Monsanto, we aim to expand our global footprint in vegetables and corn, as well as tailored digital services.'

Bayer was especially noted for its genetic resource contributions, efforts to support sustainable rice production practices, its focus on providing training for women as well as the company's Child Care Program, which is entering its second decade of operation in India. Other examples for Bayer's good practices include its work with the HarvestPlus program, its Sahyog Project and the Better Life Farming Alliance:

• As part of HarvestPlus, Bayer researchers in India are developing a hybrid pearl millet with particularly high iron content to help meet nutritional needs of the rural communities.
• Within Project Sahyog, Bayer provided hybrid rice seed to remote villagers in India, assisting them to move towards a formal seed market with more secure and sustainable incomes.
• Within the Better Life Farming Alliance, Bayer, together with Swiss Re Corporate Solutions, Netafim and the International Finance Corporation (IFC), offers smallholder farmers agro inputs, irrigation, finance and access to market, tailoring solutions to their needs.

'Smallholder farmers need to not only produce more food, but at the same time adapt their agricultural practices to changing weather conditions or newly emerging pests as a result of climate change,' said Amit Trikha, Head of Crop Management (Rice) for Bayer. 'With our quality seed, tailored solutions and digital services, we can help them overcome the challenges they are facing every day.'

The former Monsanto Company was ranked 10th in the Regional Access to Seeds Index with special reference to its geographically diverse capacity building activities reaching smallholders in Indonesia, Vietnam and India. The Climate Corporation, now a subsidiary of Bayer AG, is currently delivering hundreds of thousands of farmers in India agronomic information and advice through a pilot launch of FarmRise™ Mobile Farm Care. The company intends to expand the FarmRise platform in the future to more smallholders in Asia, Africa and South America.

The Access to Seeds Index is published by the Access to Seeds Foundation, an independent, non-profit organization that is an ally of the World Benchmarking Alliance and is based in The Netherlands. The Index aims to encourage seed companies to step up their efforts to support smallholder farmer productivity. The index scores companies in several areas. It looks at the strategy and targets in place to reach smallholders, stakeholder engagement, and how companies deal with intellectual property rights. It also looks at efforts in research and breeding, marketing and capacity-building of farmers. The index is based on publicly available information and a questionnaire that companies were asked to complete.

Improving the productivity of smallholder farmers is one of the main targets on the United Nations' Sustainable Development Goals agenda (SDGs). By measuring the seed industry's performance, the Access to Seeds Index aims to contribute to achieving these goals.

About Bayer
Bayer is a global enterprise with core competencies in the life science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2017, the Group employed around 99,800 people and had sales of 35.0 billion euros. Capital expenditures amounted to 2.4 billion euros, R&D expenses to 4.5 billion euros. For more information, go to www.bayer.com.

Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Disclaimer

Bayer AG published this content on 12 November 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 12 November 2018 10:48:02 UTC


© Publicnow 2018
All news about BAYER AG
09/28Bayer CropScience Gets Board Nod to Sell Environmental Science Business for Nearly $14 ..
MT
09/27Sandoz Granted Leave To Add New Allegations On Condition Of Trial Adjournment And Exten..
AQ
09/27Santen Pharmaceutical Co., Ltd. - Ophthalmic VEGF inhibitor Eylea Solution for Intravit..
AQ
09/26Australia's No. 2 telco Optus, government clash over massive data breach
RE
09/26U.S. farmers urge Washington to challenge Mexico's looming ban on GM corn
RE
09/26Bayer Gets Japanese Regulatory Nod For Eye Drug in Preterm Infants
MT
09/24Australia's Optus contacts customers caught in cyber attack
RE
09/22Australia's Optus says up to 10 million customers caught in cyber attack
RE
09/22Optus warns cyberattack may have exposed Australian client details
RE
09/21Singtel's Australian Unit Optus Hit by Cyberattack
DJ
More news
Analyst Recommendations on BAYER AG
More recommendations
Financials
Sales 2022 49 307 M 48 160 M 48 160 M
Net income 2022 4 494 M 4 389 M 4 389 M
Net Debt 2022 33 586 M 32 805 M 32 805 M
P/E ratio 2022 10,8x
Yield 2022 4,79%
Capitalization 46 881 M 45 791 M 45 791 M
EV / Sales 2022 1,63x
EV / Sales 2023 1,55x
Nbr of Employees 101 914
Free-Float 100,0%
Chart BAYER AG
Duration : Period :
Bayer AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BAYER AG
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Last Close Price 47,72 €
Average target price 77,41 €
Spread / Average Target 62,2%
EPS Revisions
Managers and Directors
Werner Baumann Chairman-Management Board & CEO
Wolfgang U. Nickl Chief Financial Officer
Norbert Winkeljohann Chairman-Supervisory Board
Bijoy Sagar Chief Information Technology Officer
Paul Achleitner Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
BAYER AG1.53%45 791
JOHNSON & JOHNSON-3.82%432 579
ELI LILLY AND COMPANY21.06%313 567
ROCHE HOLDING AG-15.52%269 089
ABBVIE INC.5.41%252 343
PFIZER, INC.-25.22%247 841